pentose phosphate pathway and glutathione The in health disease Pentose Phosphate Cycle - an
Description
Pre-existing conditions can change the risk-benefit calculation
This highlights the interdependence between eNOS-derived NO and DHFR stability
This increase in SOCE most likely results from the sensitization of CRAC as evidenced by the inhibitory action of CRAC selective blocker, i.e., GSK-7975A
Similarly, activating the Nrf2/HO-1 axis to enhance cellular antioxidant gene expression can hamper ferroptosis, although the potentially excessive iron release from high HO-1 expression must be considered (128)
